5′‐nucleotidase, cytosolic II genotype, and clinical outcome in patients with acute myeloid leukemia with intermediate‐risk cytogenetics-Reference-Cited by-同舟云学术

5′‐nucleotidase, cytosolic II genotype, and clinical outcome in patients with acute myeloid leukemia with intermediate‐risk cytogenetics

Published:2022-09-16 Issue:6 Volume:109 Page:755-764
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:European J of Haematology

Author:

Díaz‐Santa Johana¹,Rodríguez‐Romanos Rocío¹,Coll Rosa¹,Osca Gemma¹,Pratcorona Marta²,González‐Bártulos Marta¹,Garrido Ana²,Angona Anna¹,Talarn Carme³,Tormo Mar⁴,Arnan Montserrat⁵,Vives Susanna⁶,Salamero Olga⁷,Tuset Esperanza¹,Lloveras Natàlia¹,Díez Isabel¹,Zamora Lurdes⁶,Bargay Joan⁸,Sampol Antonia⁹,Cruz David¹,Vila Jordi¹,Sitges Marta¹^ORCID,Garcia Antoni¹⁰,Vall‐Llovera Ferran¹¹,Esteve Jordi¹²,Sierra Jorge²,Gallardo David¹^ORCID,

Affiliation:

1. Hematology Department, Institut Català d'Oncologia ‐ Hospital Dr. Josep Trueta; Institut d'Investigació Biomèdica de Girona (IDIBGI); Josep Carreras Research Institute, Girona Universitat de Girona Girona Spain

2. Hematology Department, Hospital de la Santa Creu i Sant Pau; Institut d'Investigació Biomèdica Sant Pau Universitat Autònoma de Barcelona Barcelona Spain

3. Hematology Department Institut Català d'Oncologia ‐ Hospital Joan XXIII Tarragona Spain

4. Hematology Department Hospital Clínico Universitario Valencia Spain

5. Hematology Department, Institut Català d'Oncologia – Hospital Duran I Reynals; Institut d'Investigació Biomèdica de Bellvitge (IDIBELL) Universitat de Barcelona Barcelona Spain

6. Institut Català d'Oncologia ‐ Hospital Germans Trias i Pujol; Josep Carreras Research Institute, Badalona Universitat Autònoma de Barcelona Barcelona Spain

7. Hematology Department Hospital Universitari Vall d'Hebró Barcelona Spain

8. Hematology Department Hospital de Son Llàtzer Palma de Mallorca Spain

9. Hematology Department Hospital Son Espases Palma de Mallorca Spain

10. Hematology Department Hospital Arnau de Vilanova Lleida Spain

11. Hematology Department Hospital Mutua de Terrassa Terrassa Spain

12. Hematology Department, Hospital Clínic de Barcelona, IDIBAPS University of Barcelona Barcelona Spain

Publisher

Wiley

Subject

Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ejh.13862

Reference18 articles.

1. Prognostic significance of FLT3 internal tandem repeat in patients with de novo acute myeloid leukemia treated with reinforced courses of chemotherapy

2. Cytoplasmic Nucleophosmin in Acute Myelogenous Leukemia with a Normal Karyotype

3. Cytidine deaminase polymorphisms and worse treatment response in normal karyotype AML

4. Impact of polymorphisms in drug pathway genes on disease-free survival in adults with acute myeloid leukemia

5. Potential mechanisms of resistance to cytarabine in AML patients